Trade names from 'Valsacor ®' to 'Vatorlak' - Electronic medical directory TALKDRUGS

Film-coated tablets, 40 mg, 80 mg and 160 mg.

Film-coated tablets, 320 mg.

Tablets, film-coated, 160 mg + 12.5 mg.

The tablets covered with a film cover, 320 mg + 12,5 mg, 320 mg + 25 mg.

Tablets coated with a film membrane, 80 mg + 12.5 mg.

Tablets, film-coated, 160 mg + 25 mg.

Tablets, film-coated, 450 mg.

Tablets, film-coated, 5 mg + 80 mg, 5 mg + 160 mg, 5 mg + 320 mg, 10 mg + 160 mg, 10 mg + 320 mg.

Capsules.

Tablets 0.25 μg, 0.5 μg, 1 μg.

Lyophilizate for the preparation of a solution for infusions, 500 mg and 1000 mg.

Powder for solution for infusion, 0.5 g and 1.0 g.

FARMGID CJSC Russia

Lyophilisate for solution for infusion and oral administration 0.5 g and 1.0 g.

Lyophilizate for solution for infusion and oral administration 0.5 g, 1.0 g.

Powder for solution for infusion, 0.5 g and 1.0 g of active substance.

Lyophilizate for the preparation of a solution for infusions of 500 mg and 1000 mg.

Lyophilizate for the preparation of a solution for infusions, 500 mg or 1000 mg.

Lyophilizate for the preparation of a solution for infusions, 0.5 g and 1 g.

Lyophilizate for solution for infusion, 500 mg.
Eli Lilly East SA Switzerland

Capsules of 100 mg and 200 mg.

Concentrate for the preparation of solution for infusions of 0.5 mg / ml.

Concentrate for the preparation of a solution for infusions of 20 mcg / ml.

Lyophilizate for the preparation of a solution for subcutaneous administration, 1 dose (0.5 ml).
Cream for external use, 0,15%.
Tablets 3 mg or 5 mg.
Tablets of 2.5 mg.
OZONE, LLC Russia
Tablets of 2.50 mg.
Tablets of 2.5 mg.

Solution for intravenous and intramuscular injection 30 mg / ml.

Novator Pharma, LLC United Kingdom